AbbVie Total Current Liabilities decreased by 2.7% to $42.10B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.6%, from $36.40B to $42.10B. Over 5 years (FY 2020 to FY 2025), Total Current Liabilities shows an upward trend with a 8.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to current assets may signal liquidity stress, while a decrease generally improves the current ratio.
This is the sum of all financial obligations that the company must settle within one year. It includes accounts payable,...
Standard metric across all industries to gauge short-term financial health.
total_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $28.68B | $28.53B | $35.19B | $32.52B | $34.47B | $32.71B | $29.54B | $27.59B | $32.24B | $34.77B | $37.84B | $41.52B | $41.92B | $43.06B | $38.75B | $36.40B | $39.77B | $39.39B | $43.29B | $42.10B |
| QoQ Change | — | -0.5% | +23.3% | -7.6% | +6.0% | -5.1% | -9.7% | -6.6% | +16.9% | +7.9% | +8.8% | +9.7% | +0.9% | +2.7% | -10.0% | -6.1% | +9.2% | -0.9% | +9.9% | -2.7% |
| YoY Change | — | — | — | — | +20.2% | +14.6% | -16.1% | -15.2% | -6.5% | +6.3% | +28.1% | +50.5% | +30.0% | +23.8% | +2.4% | -12.3% | -5.1% | -8.5% | +11.7% | +15.6% |